👍🚨 $MLND STARTER DD 👍🚨 I love pharma stocks and its potential. Thank you for following along as we take another dive in a great company, Millendo Therapeutics, Ann Arbor MI. As always, this is my DD and encourage you to do yours as well before investing. pic.twitter.com/NKaXj1WMgL

— John @ The Rock Trading Co. (@The_RockTrading) July 22, 2020

They have had setbacks in April, discontinuing a product Liviltide which did not meet primary endpoint and discontinued their study. Now, they are on to MLE-301 – currently advancing the development for the treatment of vasomotor symptoms (VMS) $MLND pic.twitter.com/1I1KKbyb1Q

— John @ The Rock Trading Co. (@The_RockTrading) July 22, 2020

$MLND On June 23rd, they have filed an IND for treatment of VMS, 20M women affected by VMS and expect Initiate P1 Q3-20. This is the first catalyst, which they expect to hear from FDA on this IND. pic.twitter.com/n5CJfGmSao

— John @ The Rock Trading Co. (@The_RockTrading) July 22, 2020

A word about Julie: Worked at Lycera, led partnership with $MRK $MLND, worked at Amgen, and other notable accomplishments. Will be digging through this whole crew later today. Suffice to say, with MLE301 hitting Phase 1 is huge for this company. Gap Fill 3.5 if it hits IND Approv pic.twitter.com/QKm8zeE0mr

— John @ The Rock Trading Co. (@The_RockTrading) July 22, 2020

$MLND SAVED THE BEST FOR THE LAST
1. 67% Institutional Owned – WOW. BlackRock at 5% Follow the Money
2. Insider 11%
3. LOW FLOAT
4. HUGE GAP CMING IF THEY HIT IND
Finished Q120 with $59M on hand.
More coming Soon pic.twitter.com/YJvG5AsRSP

— John @ The Rock Trading Co. (@The_RockTrading) July 22, 2020

⬇ ⬇ ⬇ What do you think of this DD? Leave a rating below!